These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16769145

  • 1. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
    Verleye M, André N, Gillardin JM.
    Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145
    [Abstract] [Full Text] [Related]

  • 2. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
    Porcher C, Peinnequin A, Pellissier S, Meregnani J, Sinniger V, Canini F, Bonaz B.
    Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
    [Abstract] [Full Text] [Related]

  • 3. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
    Grigoriadis DE, Liu XJ, Vaughn J, Palmer SF, True CD, Vale WW, Ling N, De Souza EB.
    Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
    [Abstract] [Full Text] [Related]

  • 4. Expression and effects of metabotropic CRF1 and CRF2 receptors in rat small intestine.
    Porcher C, Juhem A, Peinnequin A, Sinniger V, Bonaz B.
    Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1091-103. PubMed ID: 15637181
    [Abstract] [Full Text] [Related]

  • 5. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
    Kageyama K, Kimura R, Suga S, Ogawa Y, Suda T, Wakui M.
    Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
    [Abstract] [Full Text] [Related]

  • 6. Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain.
    Nijsen M, Ongenae N, Meulemans A, Coulie B.
    Neurogastroenterol Motil; 2005 Jun; 17(3):423-32. PubMed ID: 15916630
    [Abstract] [Full Text] [Related]

  • 7. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
    Hoare SR, Sullivan SK, Fan J, Khongsaly K, Grigoriadis DE.
    Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Corticotropin-releasing factor, urocortin 1, and their receptors in the mouse spinal cord.
    Korosi A, Kozicz T, Richter J, Veening JG, Olivier B, Roubos EW.
    J Comp Neurol; 2007 Jun 20; 502(6):973-89. PubMed ID: 17444496
    [Abstract] [Full Text] [Related]

  • 10. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF.
    J Pharmacol Exp Ther; 2004 Sep 20; 310(3):1027-34. PubMed ID: 15115804
    [Abstract] [Full Text] [Related]

  • 11. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S, Wong H, Li YW, Heman KL, Ward KA, Zeller KL, Sieracki KK, Polino JL, Godonis HE, Ren SX, Yan XX, Arneric SP, Robertson DW, Hartig PR, Grossman S, Trainor GL, Taub RA, Zaczek R, Gilligan PJ, McElroy JF.
    J Pharmacol Exp Ther; 2004 Apr 20; 309(1):293-302. PubMed ID: 14742750
    [Abstract] [Full Text] [Related]

  • 12. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
    Okuyama S, Chaki S, Kawashima N, Suzuki Y, Ogawa S, Nakazato A, Kumagai T, Okubo T, Tomisawa K.
    J Pharmacol Exp Ther; 1999 May 20; 289(2):926-35. PubMed ID: 10215672
    [Abstract] [Full Text] [Related]

  • 13. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
    Korosi A, Veening JG, Kozicz T, Henckens M, Dederen J, Groenink L, van der Gugten J, Olivier B, Roubos EW.
    Brain Res; 2006 Feb 09; 1072(1):46-54. PubMed ID: 16423327
    [Abstract] [Full Text] [Related]

  • 14. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R, Miller MF, Yamamoto K, De Groef B, Denver RJ, Kikuyama S.
    Gen Comp Endocrinol; 2007 Feb 09; 150(3):437-44. PubMed ID: 17188689
    [Abstract] [Full Text] [Related]

  • 15. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain.
    Sánchez MM, Young LJ, Plotsky PM, Insel TR.
    J Comp Neurol; 1999 Jun 07; 408(3):365-77. PubMed ID: 10340512
    [Abstract] [Full Text] [Related]

  • 16. Functional CRF receptors in BON cells stimulate serotonin release.
    von Mentzer B, Murata Y, Ahlstedt I, Lindström E, Martínez V.
    Biochem Pharmacol; 2007 Mar 15; 73(6):805-13. PubMed ID: 17184738
    [Abstract] [Full Text] [Related]

  • 17. Effects of etifoxine on stress-induced hyperthermia, freezing behavior and colonic motor activation in rats.
    Verleye M, Gillardin JM.
    Physiol Behav; 2004 Oct 15; 82(5):891-7. PubMed ID: 15451655
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.
    Dautzenberg FM, Gutknecht E, Van der Linden I, Olivares-Reyes JA, Dürrenberger F, Hauger RL.
    Biochem Pharmacol; 2004 Nov 01; 68(9):1833-44. PubMed ID: 15450949
    [Abstract] [Full Text] [Related]

  • 20. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ.
    Eur J Pharmacol; 2005 Feb 21; 509(2-3):145-53. PubMed ID: 15733549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.